These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 34826977)
21. Comparison of the clinical effects of carbomer-based lipid-containing gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: a 4-week, prospective, open-label, randomized, parallel-group, noninferiority study. Wang TJ; Wang IJ; Ho JD; Chou HC; Lin SY; Huang MC Clin Ther; 2010 Jan; 32(1):44-52. PubMed ID: 20171410 [TBL] [Abstract][Full Text] [Related]
22. Assessing clinical and molecular outcomes of prophylactic thermal pulsation therapy on ocular surface health following refractive surgery. Shetty R; Khamar P; Nair AP; Pandian PR; Vaidya TA; Trivedi D; Sethu S; Roy S; Mahajan S; Shirodkar S Indian J Ophthalmol; 2023 Apr; 71(4):1508-1516. PubMed ID: 37026292 [TBL] [Abstract][Full Text] [Related]
23. [Assessment of Langerhans Cells in the Central Cornea as Tool for Monitoring Inflammatory Changes in Patients with Keratoconjunctivitis sicca under Topical Therapy with Cyclosporine A 0.05% Eye Drops]. Schneider E; Paulsen F; Jacobi C Klin Monbl Augenheilkd; 2020 May; 237(5):669-674. PubMed ID: 32434251 [TBL] [Abstract][Full Text] [Related]
24. Association of Ramadan daytime fasting with ocular surface inflammation and dry eye. Armstrong BK; Coc IR; Agarwal P; Smith S; Navon S Int Ophthalmol; 2019 Dec; 39(12):2857-2863. PubMed ID: 31152289 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and Safety of a Water-Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye Disease: The ESSENCE-2 Randomized Clinical Trial. Akpek EK; Wirta DL; Downing JE; Tauber J; Sheppard JD; Ciolino JB; Meides AS; Krösser S JAMA Ophthalmol; 2023 May; 141(5):459-466. PubMed ID: 37022717 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of artificial tears containing trehalose and hyaluronic acid for dry eye disease in women aged 42-54 versus ≥ 55 years. Mateo-Orobia AJ; Del Prado Sanz E; Blasco-Martínez A; Pablo-Júlvez LE; Farrant S; Chiambaretta F Cont Lens Anterior Eye; 2023 Aug; 46(4):101845. PubMed ID: 37117131 [TBL] [Abstract][Full Text] [Related]
27. Effects of lubricating agents with different osmolalities on tear osmolarity and other tear function tests in patients with dry eye. Cömez AT; Tufan HA; Kocabıyık O; Gencer B Curr Eye Res; 2013 Nov; 38(11):1095-103. PubMed ID: 23841565 [TBL] [Abstract][Full Text] [Related]
29. Short-Term Effects of Ground-Level Ozone in Patients With Dry Eye Disease: A Prospective Clinical Study. Kim Y; Paik HJ; Kim MK; Choi YH; Kim DH Cornea; 2019 Dec; 38(12):1483-1488. PubMed ID: 31299662 [TBL] [Abstract][Full Text] [Related]
30. Topical Low Dose Preservative-Free Hydrocortisone Reduces Signs and Symptoms in Patients with Chronic Dry Eye: A Randomized Clinical Trial. Kallab M; Szegedi S; Hommer N; Stegmann H; Kaya S; Werkmeister RM; Schmidl D; Schmetterer L; Garhöfer G Adv Ther; 2020 Jan; 37(1):329-341. PubMed ID: 31741283 [TBL] [Abstract][Full Text] [Related]
31. Effectiveness of Combined Tear Film Therapy in Patients with Evaporative Dry Eye with Short Tear Film Breakup Time. Kim YH; Kang YS; Lee HS; Choi W; You IC; Yoon KC J Ocul Pharmacol Ther; 2017 Oct; 33(8):635-643. PubMed ID: 28846481 [TBL] [Abstract][Full Text] [Related]
32. Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial. Craig JP; Muntz A; Wang MTM; Luensmann D; Tan J; Trave Huarte S; Xue AL; Jones L; Willcox MDP; Wolffsohn JS Ocul Surf; 2021 Apr; 20():62-69. PubMed ID: 33401019 [TBL] [Abstract][Full Text] [Related]
33. The Lubricating Effect of Eye Drops Containing Hyaluronic Acid and Mallow Extract in Patients with Dry Eye Disease-A Pilot Study. Basile AA; Mandelli G; Cendali M; Hufnagel R Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241190 [No Abstract] [Full Text] [Related]
34. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy. Toker E; Asfuroğlu E Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564 [TBL] [Abstract][Full Text] [Related]
35. Autologous serum eye drops for dry eye. Pan Q; Angelina A; Marrone M; Stark WJ; Akpek EK Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009327. PubMed ID: 28245347 [TBL] [Abstract][Full Text] [Related]
36. Effect of a formulated eye drop with Tan J; Jia T; Liao R; Stapleton F Br J Ophthalmol; 2020 Oct; 104(10):1373-1377. PubMed ID: 31949092 [TBL] [Abstract][Full Text] [Related]
37. A Multicenter, Randomized, Double-Blind Evaluation of the Efficacy of TJO-087 Versus 0.05% Cyclosporine A in Moderate to Severe Dry Eye. Eom Y; Yoon KC; Kim HK; Song JS; Hyon JY; Kim HM J Ocul Pharmacol Ther; 2023; 39(1):27-35. PubMed ID: 36450107 [No Abstract] [Full Text] [Related]
38. Efficacy of Topical Cyclosporine Combined with Punctal Plugs in Treating Dry Eye Disease and Inflammation. Feng C; Wang W; Gong L; Lin T Curr Eye Res; 2024 Oct; ():1-14. PubMed ID: 39373208 [TBL] [Abstract][Full Text] [Related]
39. Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated With Graft-versus-Host Disease. Yin J; Kheirkhah A; Dohlman T; Saboo U; Dana R Am J Ophthalmol; 2018 Jun; 190():17-23. PubMed ID: 29572107 [TBL] [Abstract][Full Text] [Related]
40. Efficacy, safety, and acceptability of a lipid-based artificial tear formulation: a randomized, controlled, multicenter clinical trial. Simmons PA; Carlisle-Wilcox C; Chen R; Liu H; Vehige JG Clin Ther; 2015 Apr; 37(4):858-68. PubMed ID: 25659956 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]